Small-Molecule Inhibitors of the TLR3/dsRNA Complex
Journal of the American Chemical Society2011Vol. 133(11), pp. 3764–3767
Citations Over TimeTop 14% of 2011 papers
Abstract
The protein-RNA interface has been regarded as "undruggable" despite its importance in many biological processes. The toll-like receptor 3 (TLR3)/double-stranded RNA (dsRNA) complex provides an exciting target for a number of infectious diseases and cancers. We describe the development of a series of small-molecule probes that were shown to be competitive inhibitors of dsRNA binding to TLR3 with high affinity and specificity. In a multitude of assays, compound 4a was profiled as a potent antagonist to TLR3 signaling and also repressed the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β.
Related Papers
- → Double-Stranded RNA Induces an Antiviral Defense Status in Epidermal Keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-Mediated Differential Signaling(2008)178 cited
- → Recognition of Double-Stranded RNA and Regulation of Interferon Pathway by Toll-Like Receptor 10(2018)90 cited
- → EXPLORING DOUBLE‐STRANDED RNA AS A POSSIBLE CHEMOTHERAPEUTIC AGENT(2009)
- → TLR3 Tolls for dsRNA(2001)
- → TLR3 Tolls for dsRNA(2001)